Reappraisal of COVID-19 Risk for Patients with Inflammatory Bowel Disease (IBD): Withdrawal of the British Society of Gastroenterology IBD Risk Grid

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Ungaro, Ryan C.
    • Other Affiliation: Icahn School of Medicine at Mount Sinai
  • Kappelman, Michael D.
    • Affiliation: School of Medicine, Department of Pediatrics
Abstract
  • Early in the pandemic, there was significant concern about how COVID-19 may impact patients with inflammatory bowel disease (IBD). Would IBD, as a chronic immune-mediated condition, be a risk factor for more severe COVID-19? Would medications used to treat IBD, in particularly immunosuppressants, increase the likelihood of hospitalization or death due to COVID-19? However, at the start of the pandemic there was a paucity of data to guide decision making for patients with IBD. In this setting, many national and international societies issued statements on management of IBD to provide initial guidance to gastroenterologists and patients with IBD. The British Society of Gastroenterology (BSG) published an IBD risk grid for COVID-19 severity in April 2020 that proposed a framework for categorizing patients with IBD into those more likely to be vulnerable to COVID-19 primarily based on co-morbidities and disease characteristics. Patients deemed at moderate risk were advised to practice stringent social distancing while those at high risk were recommended to practice “shielding,” the strictest advice for isolating from others. The authors of the BSG IBD risk grid recently issued a statement withdrawing this guidance noting a number of factors including that the vast majority of IBD patients are not at increased risk of adverse COVID-19 outcomes, the reduced severity of disease with recent variants, and the effectiveness of COVID-19 vaccines.
Date of publication
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • Gastroenterology
Language
  • English
Version
  • Postprint
ISSN
  • 1528-0012

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details Reappraisal_of_COVID-19_Risk.pdf 2022-10-07 Public Download